Search

for
Search:

Research

5 / 1000+ results

Cultural Sensitivity and Challenges in Management of the Transgender Patient With End-Stage Renal Disease in Transplantation

research Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation

13 citations , March 2016 in “Progress in Transplantation”

This review discusses the unique challenges faced by transgender patients with end-stage renal disease during the transplant process and outlines current management recommendations, but it reports no new clinical results.

research Hormone-related hair disorders - from clinical needs to new therapeutic perspectives

August 2006 in “Experimental dermatology”

This review discusses hormone-related hair disorders and explores potential therapies, including microparticle-based drug delivery systems, without providing new clinical findings.

research Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.

6 citations , April 2017 in “JAMA Dermatology”

This study concluded that visits to emergency and urgent care centers for severe sunburn treatment are largely avoidable and contribute to significant healthcare costs.

The Role of Glypican-4, Thyroid Stimulating Hormone, and Reproductive Hormones in Polycystic Ovary Syndrome Progress Among Iraqi Women

research The role of glypican-4, thyroid stimulating hormone, and reproductive hormones in polycystic ovary syndrome progress among Iraqi women

July 2024 in “International Journal of Chemical and Biological Sciences”

This study reported that women with polycystic ovary syndrome had higher glypican-4 levels compared to controls, indicating its significant role in hormonal regulation associated with the condition.

research A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome

98 citations , May 2020 in “Journal of Functional Morphology and Kinesiology”

This review finds that vigorous aerobic exercise and resistance training may improve insulin sensitivity and androgen levels in women with PCOS, though more research is needed for definitive conclusions.

View more "hormone sensitivity" in research →

Community Join

5 / 1000+ results

community 13 Years on Fin, Losing Effectiveness, Started 0.5 Dut Once a Week, Getting Strange Nipple Sensitivity, Is This Something That Will Go Away? (Blood Test Results After 13 Years Included)

2 upvotes 1 year ago

After 13 years on finasteride, OP is experiencing reduced effectiveness and has started taking 0.5 mg of dutasteride weekly, noticing nipple sensitivity as a side effect. OP plans to increase the dutasteride dosage and retest hormone levels, while others suggest adjusting the dosage or trying different forms of dutasteride.

community Why do we have head hair in first place if we evolved to start losing it in some cases as soon as puberty hits

140 upvotes 11 months ago

Hair loss is influenced by genetics and sensitivity to hormones like DHT. Treatments like Minoxidil and finasteride are commonly used, and baldness persists as it doesn't affect reproductive success.

community Stopped Fin 90 days ago, still experiencing side effects.

21 upvotes 5 days ago

A user stopped taking finasteride 90 days ago but still experiences side effects like reduced sensitivity and erectile issues. They are considering micro-dosing topical finasteride and exploring other treatments like exercise and diet changes, while others suggest checking hormone levels and trying alternatives like RU58841 or dutasteride.

community Ray Peat: Testosterone Isn’t the Culprit, Prolactin and Cortisol Drive Hair Loss (2016)

in Research/Science 110 upvotes 10 months ago

Prolactin and cortisol are identified as key factors in hair loss, with stress hormones impacting hair shedding. Finasteride and minoxidil are effective treatments, while DHT's role and individual sensitivity are significant factors.

community Interesting new publication suggesting that MPB should be assessed as a early warning sign for type-2 diabetes.

15 upvotes 8 years ago

Male pattern baldness (MPB) may be an early warning sign for type 2 diabetes due to its association with insulin resistance. Treatments discussed include testosterone therapy and finasteride, which affects hormone levels related to hair loss and insulin sensitivity.

View more "hormone sensitivity" in community →

Learn

8 / 801 results

learn Hair Transplant

What causes male pattern baldness? Male pattern baldness is caused by genetic sensitivity to the hormone DHT.

learn Cyproterone

a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

learn Bicalutamide

a nonsteroidal anti-androgen, most commonly used orally for women

learn Neem Oil

natural substance from Neem tree with medicinal and pesticidal properties

learn Centella

Sensitive to hormones? A centella scalp mask may help ease hidden inflamm Centella asiatica has anti-inflammatory and wound-healing effects in animal and cell studies, but no published research has tested a centella scalp mask on the human scalp, in hormonal contexts or otherwise, and no community reports were found of one being used this way.

learn Estradiol

Why is Estradiol used to treat hair loss in women and transgender people undergoing hormone therapy? Estradiol helps treat hair loss by balancing hormones and supporting hair follicle health.

learn procapil

Want to stop hormonal hair loss without touching your hormone levels? Procapil could block the enzyme doing the damage. Procapil's supplier describes it as inhibiting 5-alpha reductase at the scalp without changing hormone levels, but the published support is cell and animal work plus one small human study of a caffeine-plus-Procapil formula. It is a cosmetic ingredient, not an approved hair-loss treatment, and no trial has compared it with finasteride or minoxidil.

learn Clascoterone

Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.

View more "hormone sensitivity" in learn →

Clinics

6 / 71 results

All 71 clinic results →

Experts

— no results

Try a deeper search in experts →